7845465|t|Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.
7845465|a|Alzheimer's disease (AD) is the most common cause of progressive intellectual failure in aged humans. AD brains contain numerous amyloid plaques surrounded by dystrophic neurites, and show profound synaptic loss, neurofibrillary tangle formation and gliosis. The amyloid plaques are composed of amyloid beta-peptide (A beta), a 40-42-amino-acid fragment of the beta-amyloid precursor protein (APP). A primary pathogenic role for APP/A beta is suggested by missense mutations in APP that are tightly linked to autosomal dominant forms of AD. A major obstacle to elucidating and treating AD has been the lack of an animal model. Animals transgenic for APP have previously failed to show extensive AD-type neuropathology, but we now report the production of transgenic mice that express high levels of human mutant APP (with valine at residue 717 substituted by phenylalanine) and which progressively develop many of the pathological hallmarks of AD, including numerous extracellular thioflavin S-positive A beta deposits, neuritic plaques, synaptic loss, astrocytosis and microgliosis. These mice support a primary role for APP/A beta in the genesis of AD and could provide a preclinical model for testing therapeutic drugs.
7845465	0	29	Alzheimer-type neuropathology	Disease	MESH:C536598
7845465	44	48	mice	Species	10090
7845465	64	69	V717F	ProteinMutation	tmVar:p|SUB|V|717|F;HGVS:p.V717F;VariantGroup:0;CorrespondingGene:351;RS#:63750264;CorrespondingSpecies:9606;CA#:127792
7845465	70	100	beta-amyloid precursor protein	Gene	11820
7845465	102	121	Alzheimer's disease	Disease	MESH:D000544
7845465	123	125	AD	Disease	MESH:D000544
7845465	167	187	intellectual failure	Disease	MESH:D051437
7845465	196	202	humans	Species	9606
7845465	204	206	AD	Disease	MESH:D000544
7845465	231	246	amyloid plaques	Disease	MESH:D058225
7845465	300	313	synaptic loss	Disease	MESH:D012183
7845465	315	337	neurofibrillary tangle	Disease	MESH:D055956
7845465	352	359	gliosis	Disease	MESH:D005911
7845465	365	380	amyloid plaques	Disease	MESH:D058225
7845465	419	425	A beta	Gene	351
7845465	463	493	beta-amyloid precursor protein	Gene	351
7845465	531	541	APP/A beta	Gene	351
7845465	639	641	AD	Disease	MESH:D000544
7845465	688	690	AD	Disease	MESH:D000544
7845465	797	799	AD	Disease	MESH:D000544
7845465	868	872	mice	Species	10090
7845465	901	906	human	Species	9606
7845465	924	974	valine at residue 717 substituted by phenylalanine	ProteinMutation	tmVar:p|SUB|V|717|F;HGVS:p.V717F;VariantGroup:0;CorrespondingGene:351;RS#:63750264;CorrespondingSpecies:9606;CA#:127792
7845465	1046	1048	AD	Disease	MESH:D000544
7845465	1083	1095	thioflavin S	Chemical	MESH:C009462
7845465	1105	1111	A beta	Gene	11820
7845465	1122	1130	neuritic	Disease	MESH:D058225
7845465	1140	1153	synaptic loss	Disease	MESH:D012183
7845465	1155	1167	astrocytosis	Disease	MESH:D005911
7845465	1172	1184	microgliosis	Disease	
7845465	1192	1196	mice	Species	10090
7845465	1224	1234	APP/A beta	Gene	11820
7845465	1253	1255	AD	Disease	MESH:D000544
7845465	Association	MESH:C536598	11820
7845465	Association	MESH:C536598	RS#:63750264;HGVS:p.V717F;CorrespondingGene:351
7845465	Association	MESH:D000544	351
7845465	Association	MESH:D058225	351
7845465	Bind	MESH:C009462	11820
7845465	Association	MESH:D000544	11820
7845465	Association	MESH:C536598	351

